Sandip Kapadia - Mar 29, 2024 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Christian Ulrich, Attorney-in-Fact
Stock symbol: HRMY
Transactions as of: Mar 29, 2024
Transactions value $: -$269,077
Form type: 4
Date filed: 4/2/2024, 04:31 PM
Previous filing: Jan 26, 2024
Next filing: May 23, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HRMY	Common Stock	Options Exercise	$0	+15K		$0.00	15K	Mar 29, 2024	Direct
transaction	HRMY	Common Stock	Tax liability	-$269K	-8.01K	-53.42%	$33.58	6.99K	Mar 29, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRMY	Restricted Stock Units	Options Exercise	$0	-15K	-50%	$0.00	15K	Mar 29, 2024	Common Stock	15K		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
F2	This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023 and 25% of the shares vested on March 29, 2024, with the remaining 25% of the underlying shares scheduled to vest on March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

Content

Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023 and 25% of the shares vested on March 29, 2024, with the remaining 25% of the underlying shares scheduled to vest on March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.